跳至主要内容
临床试验/DRKS00017896
DRKS00017896已完成不适用

Predictors of psoriasis on response to systemic therapy - PREDICT

AbbVie Deutschland GmbH & Co. KG0 个研究点目标入组 381 人开始时间: 2019年11月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
381

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Adult patients (= 18 years) with moderate to severe plaque psoriasis (defined by the European Consensus 2011 [5]) and present indication for conventional systemic psoriasis treatment (fumaric acid ester, MTX, cyclosporine, etc.) who are naive (untreated) to conventional psoriasis system therapy at the time of initiation of observation.

排除标准

  • Patients who have already been treated with systemic psoriasis medications, i.e. are not naive to systemic psoriasis therapy and/or patients who are receiving PUVA therapy and/or patients who cannot or do not wish to sign the informed consent form

研究者

相似试验